Artivion Q3 revenue $76.8M (+6% GAAP, +11% constant currency); net loss $0.34/share

ARTIVION, INC.

2022-Q3 EPS reported -$0.53 revenue$234,391,000

Revenue $76.8M, up 6% GAAP and 11% constant currency vs Q3 2021.
On-X revenues up 17% GAAP and 19% constant currency; tissue processing up 13% constant currency.
Net loss ($13.7M) or ($0.34)/share vs net income $10.6M ($0.26) in Q3 2021. Includes $4.7M PROACT Xa termination charge and $3.7M FX loss.
Non-GAAP net loss ($1.9M) or ($0.05)/share vs ($1.2M) ($0.03) prior year.
2022 outlook: narrowing constant currency revenue growth to 9-10%; full-year revenue expected $313M-$316M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

ARTIVION, INC. reported third quarter ended September 30, 2022 results: revenue $76.8 million, net income ($13.7) million, or ($0.34) per fully diluted common share, EPS ($0.34) per fully diluted common share. Guidance reaffirmed.

Period: third quarter ended September 30, 2022
Revenue: $76.8 million
Net income: ($13.7) million, or ($0.34) per fully diluted common share
EPS: ($0.34) per fully diluted common share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Total revenues for the third quarter of 2022 were $76.8 million

View on SEC.gov

Browse all earnings releases →

ARTIVION, INC. filing history →

Source: SEC EDGAR

accession 0000784199-22-000184

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.